ARCHIVE

• Health Science Research Group Surveying State of IRBs in Japan
  September 20, 2004

• OTC NEWS IN BRIEF
  September 20, 2004

• Switching to Olanzapine Monotherapy Improves QOL: Eli Lilly Japan
  September 20, 2004

• NEW PRODUCTS
  September 20, 2004

• The 7th International Symposium on Clinical Trials
  September 20, 2004

• GEYMS: World's First Volume CT LightSpeed VCT
  September 20, 2004

• Ban on Internet Drug Sales Notified
  September 20, 2004

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  September 20, 2004

• 67.7% of People Wish to See Reform of Social Insurance Programs: Public Opinion Poll
  September 20, 2004

• Public Course to Be Started to Train Experts on Life Ethics: Univ. of Tokyo
  September 20, 2004

• Applications for Hospitals Run by Stock Companies to Be Received from Oct
  September 20, 2004

• BUSINESS NEWS IN BRIEF
  September 20, 2004

• Daiichi to Carry Out Organizational Reforms
  September 20, 2004

• Fukujin, Seiwa Sangyo Form Business Alliance
  September 20, 2004

• Bushu Pharmaceuticals Expanding Contract Manufacturing System
  September 20, 2004

• Chugai to Establish Clinical Development Subsidiary
  September 20, 2004

• Norvasc Ranks Top in 1st Half of 2004: IMS Data
  September 20, 2004

• BI Reinforcing Independent Marketing System, Particularly in US: Dr Banchi
  September 20, 2004

• Human ES Cells to Reduce Cost, Risk of Clinical Trials: PMSRL Seminar
  September 20, 2004

• J&J to Strengthen Collaboration between 6 Subsidiaries in Japan: Mr Perkins
  September 20, 2004

ページ

• « 先頭
• ‹ Prev
• …
• 509
• 510
• 511
• 512
• 513
• 514
• 515
• 516
• 517
• …
• Next ›
• 最終 »